Nalaganje...
Environmental Risk Assessment of Clinical Trials Involving Modified Vaccinia Virus Ankara (MVA)-Based Vectors
The modified vaccinia virus Ankara (MVA) strain, which has been developed as a vaccine against smallpox, is since the nineties widely tested in clinical trials as recombinant vector for vaccination or gene therapy applications. Although MVA is renowned for its safety, several biosafety aspects need...
Shranjeno v:
| Main Authors: | , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Bentham Science Publishers
2013
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4031919/ https://ncbi.nlm.nih.gov/pubmed/24397528 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/156652321306140103221941 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|